David Moskowitz
David Moskowitz
negative outcome positive trial
A negative outcome in this trial is more magnified than a positive one.
blatant decision protecting says
This is really bad. It is such a blatant decision that says Merck did not do the right thing about protecting patients.
add further pressure suicidal warning
A new warning (on suicidal thoughts) could further add to pressure on the product.
cases company number squeeze stability types
The squeeze is coming, ... With this number of cases and these types of awards, the stability of the company is at risk.
companies good potential products
As potential patients, we would want these companies to make incremental improvements. Without it, we would end up only with first-in-class products that are not as good as they could be.
affected boom failed failure indian kidney local minorities orleans past people realize saw three weeks
The American people saw unforgettably how federal, state, and local governments failed the people of New Orleans just three weeks ago. What the American people don't realize is how they've all been short-changed for the past three years. Minorities are much more affected by kidney failure than whites. There's a dialysis boom on Indian reservations.
achieved action against although asia asked both cases effective equally ignored ill novel past president southeast success three touch treating treatment virus west
President Bush's action, although timely, may be ill advised. For the past three years, both the CDC and the WHO have steadfastly ignored our novel anti-viral approach, which has achieved over 80% treatment success in West Nile virus encephalitis and which should be equally effective against avian influenza. If the WHO had put us in touch with clinicians in Southeast Asia treating avian influenza cases as we've asked for the past three winters, we'd already know by now.
beyond case cases patients relevant taken
What Merck has going for them in this case is that the plaintiffs are still alive. Beyond that, these are the more relevant cases to the plaintiffs because the patients allegedly have taken the drug for more than the 18-month interval. It makes the case more compelling.